Novartis today announced that it has entered into a development and licensing agreement with Biological E Limited (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.
The Global Post published a write-up of the June 27th Hill hearing featuring Dr. Peter Hotez: “Calling Attention to tropical diseases on Capitol Hill”
Peter J. Hotez, president of the Sabin Vaccine Institute and dean of the new National School of Tropical Medicine at Baylor College of Medicine, addressed concerns from lawmakers about the relationship between immigration and NTDs. Hotez acknowledged that immigration may be contributing to the incidence of NTDs in the US, but that poverty played a big role.
Dr. Peter Hotez co-authored a report on the prevalence of NTDs in Texas and the American South in PLOS Neglected Tropical Diseases.
Drs. Gregory Simon, Neeraj Mistry, and Peter Hotez's article on NTD impact on child health appeared in the BMJ journal
Dr. Peter Hotez testified on Neglected Tropical Diseases before the House Sub Committee on Africa, Global Health, Global Human Rights, and international organizations on June 27th.
Highlight from the testimony:
Dr. Peter Hotez contributed to sections on neglected tropical diseases.
In 2005, the concept of bundling together multiple chronic parasitic and related infections into the category of neglected tropical diseases (NTDs) was proposed because they could be targeted simultaneously with a package of low cost and donated drugs.
In Scientific American, Ciro de Quadros discusses the victories and challenges in eradicating polio.
Peter Hotez discusses a new European neglected diseases center in Greece in NEO Magazine.